Form 4: Orchestra BioMed Officer Joshua Aiello Reports Routine Stock Transaction for Tax Withholding

Orchestra BioMed Holdings, Inc.'s Principal Accounting Officer, Joshua Aiello, reported a routine disposition of 393 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Joshua Aiello, Principal Accounting Officer of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction involving the company's common stock.
• On June 18, 2025, 393 shares of Common Stock were disposed of at a deemed price of $2.99 per share.
• This disposition was solely for the purpose of satisfying tax withholding obligations associated with the vesting of restricted stock units.
• The filing explicitly states that no shares were sold in the open market as a result of this transaction.
• Following this transaction, Mr. Aiello beneficially owns 4,329 shares of Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-market disposition for tax purposes, indicating a neutral impact on company sentiment. It's neither significantly positive nor negative.

Positives

• The transaction was a non-market disposition, meaning no shares were sold into the market, which avoids direct selling pressure on the stock price.
• It represents a routine tax-related event following the vesting of restricted stock units, indicating the fulfillment of compensation agreements.

Negatives

• A reduction of 393 shares in the officer's direct beneficial ownership, although for tax purposes, still reduces the total number of shares held.

Future Outlook

N/A This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance.

Management Comments

• The disposition represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units.
• No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Industry Context

This is a routine insider transaction filing (Form 4) common across all publicly traded companies when executives' restricted stock units vest and shares are withheld for tax purposes. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a non-market disposition for tax purposes, not a sale into the open market.
• Positive for the executive (Joshua Aiello) as it represents the vesting of compensation and fulfillment of tax obligations.

Key Dates

Keywords

Orchestra BioMed Holdings Inc., OBIO, Joshua Aiello, SEC Form 4, Insider Transaction, Stock Ownership, Restricted Stock Units, Tax Withholding, Beneficial Ownership